A commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. INSY announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pharmaceutical cannabidiol (CBD) for the treatment of glioblastoma multiforme (GBM), the […]